RESUMEN
AIM: To conduct a pilot randomized trial of an intervention to improve adolescent question-asking and provider education during paediatric diabetes visits. METHODS: Adolescents aged 11 to 17 with type 1 diabetes and their parents were enrolled from two urban tertiary paediatric clinics. Adolescents were randomised to the intervention group or control group. Adolescent consultations were audio-recorded, their HbA1c level was recorded, and they completed surveys after three clinic appointments. The intervention group completed a question prompt list and watched a video on a tablet with their parents before meeting their doctor and completed a short evaluation after each visit. RESULTS: Six consultant endocrinologists and ninety-nine adolescents and their parents participated. The intervention increased adolescents' question asking and provider education in diabetes encounters. Total patient question-asking across the 3 consultations and a higher baseline HbA1c at time one was significantly associated with HbA1c at time three. CONCLUSIONS: Question prompt lists and an educational video are useful tools to increase adolescents' question-asking and communication between adolescents and their providers. PRACTICE IMPLICATIONS: Interventions that encourage adolescents' question-asking in healthcare encounters may lead to more meaningful providers-adolescents' communication and tailored education. Interventions to improve professionals' listening, communication and educational skills are also required.
Asunto(s)
Comunicación , Diabetes Mellitus Tipo 1 , Relaciones Médico-Paciente , Humanos , Adolescente , Masculino , Proyectos Piloto , Femenino , Diabetes Mellitus Tipo 1/terapia , Niño , Hemoglobina Glucada/análisis , Educación del Paciente como Asunto/métodos , Padres/psicología , Encuestas y CuestionariosAsunto(s)
Predisposición Genética a la Enfermedad/genética , Polimorfismo de Nucleótido Simple/genética , Esquizofrenia/genética , Adolescente , Adulto , Anciano , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Genotipo , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Adulto JovenAsunto(s)
Trastorno Bipolar/genética , Sitios Genéticos/genética , Predisposición Genética a la Enfermedad/genética , Trastorno Depresivo Mayor/genética , Femenino , Estudio de Asociación del Genoma Completo , Humanos , Masculino , Linaje , Polimorfismo de Nucleótido Simple/genética , Factores de RiesgoRESUMEN
This article demonstrates reflective practice by examining a critical incident that took place at a children's burns unit. The development of reflective skills is documented using a method of structured reflection. The concepts of aesthetics, personal knowing, empirics and ethics are considered to reflect on the critical incident. Reflection is considered in the context of developing a portfolio to analyse and demonstrate learning in practice.
Asunto(s)
Competencia Profesional , Análisis y Desempeño de Tareas , Niño , Ética Profesional , HumanosRESUMEN
Driven in part by a resurgent interest in social inequality and health, and in part by increasing scrutiny of the social and health consequences of neoliberal economic reform, principles of health equity and social justice, the centerpieces of the Health for All strategy drafted at Alma Ata in 1978, are once again at center stage in global public health debates. Whether and how equity in access to health care can be maintained in a context of market-based health sector reform has not been systematically addressed, particularly from the perspective of local communities. This paper will explore how health reform affects health care in post-socialist Mongolia. Through a mixed-methods household-based study of low-to-middle income communities in urban and rural Mongolia we find that despite explicit and concerted efforts to reduce inequities, the reform system is unable to provide equitable health care either vertically or horizontally. Emphasis on privatization of the secondary and tertiary sectors of the system, coupled with deployment of universally-accessible, but from a clinical standpoint, limited, version of essential primary care, produces a fragmented system. Particularly for the vulnerable poor, access to services beyond the primary care system is compromised by financial, opportunity, and informational cost barriers. This research suggests that new models of health reform are needed that will effectively bridge the growing gaps between public and private resources, primary and secondary and/or tertiary care, and clinical and public health services.
Asunto(s)
Reforma de la Atención de Salud/economía , Reforma de la Atención de Salud/ética , Transición de la Salud , Disparidades en Atención de Salud/economía , Política , Pobreza/economía , Administración en Salud Pública/economía , Administración en Salud Pública/ética , Reforma de la Atención de Salud/legislación & jurisprudencia , Gastos en Salud/tendencias , Accesibilidad a los Servicios de Salud , Investigación sobre Servicios de Salud , Humanos , Mortalidad Materna/tendencias , Mongolia/epidemiología , Pobreza/estadística & datos numéricos , Administración en Salud Pública/legislación & jurisprudencia , Investigación Cualitativa , Características de la Residencia , Salud Rural , Justicia Social , Salud UrbanaRESUMEN
Phenolphthalein induces tumors in rodents but because it is negative in assays for mutation in Salmonella and in mammalian cells, for DNA adducts and for DNA strand breaks, its primary mechanism does not seem to be DNA damage. Chromosome aberration (Ab) induction by phenolphthalein in vitro is associated with marked cytotoxicity. At very high doses, phenolphthalein induces weak increases in micronuclei (MN) in mouse bone marrow; a larger response is seen with chronic treatment. All this suggests genotoxicity is a secondary effect that may not occur at lower doses. In heterozygous TSG-p53((R)) mice, phenolphthalein induces lymphomas and also MN, many with kinetochores (K), implying chromosome loss. Induction of aneuploidy would be compatible with the loss of the normal p53 gene seen in the lymphomas. Here we address some of the postulated mechanisms of genotoxicity in vitro, including metabolic activation, inhibition of thymidylate synthetase, cytotoxicity, oxidative stress, DNA damage and aneuploidy. We show clearly that phenolphthalein does not require metabolic activation by S9 to induce Abs. Inhibition of thymidylate synthetase is an unlikely mechanism, since thymidine did not prevent Ab induction by phenolphthalein. Phenolphthalein dramatically inhibited DNA synthesis, in common with many non-DNA reactive chemicals that induce Abs at cytotoxic doses. Phenolphthalein strongly enhances levels of intracellular oxygen radicals (ROS). The radical scavenger DMSO suppresses phenolphthalein-induced toxicity and Abs whereas H(2)O(2) potentiates them, suggesting a role for peroxidative activation. Phenolphthalein did not produce DNA strand breaks in rat hepatocytes or DNA adducts in Chinese hamster ovary (CHO) cells. All the evidence points to an indirect mechanism for Abs that is unlikely to operate at low doses of phenolphthalein. We also found that phenolphthalein induces mitotic abnormalities and MN with kinetochores in vitro. These are also enhanced by H(2)O(2) and suppressed by DMSO. Our findings suggest that induction of Abs in vitro is a high-dose effect in oxidatively stressed cells and may thus have a threshold. There may be more than one mechanism operating in vitro and in vivo, possibly indirect genotoxicity at high doses and also chromosome loss, both of which would likely have a threshold.
Asunto(s)
Aberraciones Cromosómicas , Fenolftaleína/toxicidad , Animales , Antioxidantes/farmacología , Células CHO , Catárticos/toxicidad , Línea Celular , Quelantes/farmacología , Cricetinae , ADN/biosíntesis , Aductos de ADN/metabolismo , Daño del ADN , Deferoxamina/farmacología , Dimetilsulfóxido/farmacología , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Humanos , Peróxido de Hidrógeno/toxicidad , Técnicas In Vitro , Ratones , Microsomas Hepáticos/metabolismo , Mutágenos/toxicidad , Estrés Oxidativo , Fenantrolinas/farmacología , Ratas , Especies Reactivas de Oxígeno/metabolismo , Timidina/farmacologíaRESUMEN
Fas-mediated apoptosis is an important regulator of cell survival, and abnormalities in this system have been shown to result in a number of human pathological conditions. A secreted member of the tumor necrosis factor receptor superfamily, DcR3, was recently reported to be amplified in human lung and colon cancers as a negative regulator of Fas-mediated apoptosis. We identified this gene, which we call M68. M68 genomic DNA, mRNA, and protein levels were examined in a series of human gastrointestinal tract tumors. Using M68 immunohistochemistry and a scoring system similar to that used for HER-2/neu, we found that M68 protein was overexpressed in 30 of 68 (44%) human adenocarcinomas of the esophagus, stomach, colon, and rectum. Tumors examined by Northern blot revealed M68 mRNA highly elevated in a similar fraction of primary tumors from the same gastrointestinal tract regions, as well as in the colon adenocarcinoma cell lines SW480 and SW1116. Further, we found M68 protein to be overexpressed in a substantial number of tumors in which gene amplification could not be detected by fluorescence in situ hybridization or quantitative genomic PCR, suggesting that overexpression of M68 may precede amplification in tumors. Finally, we find that M68 lies within a four-gene cluster that includes a novel helicase-like gene (NHL) related to RAD3/ERCC2, a plasma membrane Ras-related GTPase and a member of the stathmin family, amplification or overexpression of which may also contribute to cell growth and tumor progression.
Asunto(s)
Factores de Ribosilacion-ADP , Cromosomas Humanos Par 20/genética , Neoplasias Esofágicas/genética , Neoplasias Gastrointestinales/genética , Regulación Neoplásica de la Expresión Génica , Glicoproteínas de Membrana , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Receptores de Superficie Celular/biosíntesis , Secuencia de Aminoácidos , Apoptosis , Mapeo Cromosómico , ADN Helicasas/genética , ADN Complementario/genética , Etiquetas de Secuencia Expresada , GTP Fosfohidrolasas/genética , Amplificación de Genes , Genes , Humanos , Proteínas de la Membrana/genética , Datos de Secuencia Molecular , Factores de Crecimiento Nervioso/genética , Reacción en Cadena de la Polimerasa , ARN Mensajero/biosíntesis , ARN Neoplásico/genética , Receptores de Superficie Celular/genética , Receptores del Factor de Necrosis Tumoral , Miembro 6b de Receptores del Factor de Necrosis Tumoral , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Estatmina , Receptor fas/biosíntesis , Receptor fas/fisiologíaRESUMEN
Chromosome aberrations can occur by secondary mechanism(s) associated with cytotoxicity, induced by chemicals that do not attack DNA. Aberrations are formed from DNA double-strand breaks, and DSBs are known to be induced by nonmutagenic (Ames test negative) noncarcinogens at toxic levels [Storer et al. (1996): Mutat Res 368:59-101]. Here, 8 of 12 of these chemicals caused aberrations in CHO cells at cytotoxic doses, and often only when cell counts (survival) at 20 hr approached < or =50% of controls. Five of eight noncarcinogens (2,4,-dichlorophenol, dithiocarb, menthol, phthalic anhydride, and ethionamide) and one of two equivocal carcinogens (bisphenol A) caused aberrations, usually over a narrow dose range with steeply increasing cytotoxicity. Phthalic anhydride and ethionamide were positive only at doses with precipitate. Phenformin was negative even at toxic doses and ephedrine and phenylephrine were negative and gave little toxicity. Aberrations were also induced by metabolic poisons, 2,4-dinitrophenol, (uncouples oxidative phosphorylation), and sodium iodoacetate, (Nal; blocks ATP production). Five of the chemicals that induced aberrations in CHO cells were tested in human TK6 cells and four were positive, the fifth being equivocal. Stable aberrations (translocations) were induced in human cells by Nal. Clearly, chemicals can give "false-positive" results in the chromosome aberration assay at cytotoxic levels, though cytotoxicity does not always produce aberrations, so that further information (e.g., DNA reactivity) is needed to determine whether a result is a "false-positive." Primary DNA-damaging chemicals such as alkylators are also cytotoxic, but give strong increases in aberrations without marked initial toxicity by the measures used here, although the aberrations they induce do reduce long-term survival in colony-forming assays.
Asunto(s)
Muerte Celular , Aberraciones Cromosómicas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Animales , Biotransformación , Células CHO , Carcinógenos/toxicidad , Células Cultivadas , Cricetinae , Daño del ADN , Dinitrofenoles/toxicidad , Ditiocarba/toxicidad , Humanos , Yodoacetatos/toxicidad , Ácido Yodoacético , Hígado/ultraestructura , Linfocitos/ultraestructura , Mentol/toxicidad , Pruebas de MutagenicidadRESUMEN
The human lymphoblastoid cell lines TK6 (normal p53) and WI-L2-NS or WTK1 (mutant p53) differ in sensitivity to killing and induction of gene mutations and chromosome aberrations by ionizing radiation. This may be related to decreased apoptosis in the cells with mutated p53, such that more damaged cells survive. We compared the response of the two cell types to various chemicals. First, to ensure that the thymidine kinase deficiency does not increase the sensitivity of TK6 tk+/- cells to mutagens, we demonstrated that they were not hypersensitive to aberration induction by altered DNA precursor pools or DNA synthesis inhibition, by aphidicolin (APC), methotrexate, hydroxyurea (HU), cytosine arabinoside and thymidine. TK6 cells were then compared with WI-L2-NS or WTK1 cells. With APC, HU, methyl methanesulfonate (MMS), ethyl nitrosourea (ENU) and etoposide (etop), TK6 cells had more apoptosis in the first two days after treatment. Fewer aberrations were seen in normal p53 TK6 cells than the mutant p53 WI-L2-NS cells, ranging from very little difference between the two cell types with MMS to very large differences with ENU and etop. For MMS and ENU we followed cultures for several days, and found that WI-L2-NS cells underwent delayed apoptosis 3 to 5 days after treatment, in parallel with published observations with ionizing radiation. WI-L2-NS cells also had a delayed increase in aberrations (up to 5 days post-treatment) when no aberrations remained in TK6 cells. Colony forming efficiency was measured for APC, MMS and ENU, and was greater in the p53 mutant cells. Our results show that normal p53 function is required for rapid and efficient apoptosis in these lymphoblastoid cells with DNA synthesis inhibitors, alkylating agents and a topoisomerase II inhibitor, and support the hypothesis that induced levels of aberrations are higher in p53 mutant cells because of a failure to remove damaged cells by apoptosis.
Asunto(s)
Alquilantes/toxicidad , Antineoplásicos/toxicidad , Apoptosis/fisiología , Aberraciones Cromosómicas , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , Inhibidores de Topoisomerasa II , Proteína p53 Supresora de Tumor/metabolismo , Afidicolina/toxicidad , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Linfocitos B , División Celular/efectos de los fármacos , División Celular/efectos de la radiación , Línea Celular , Citarabina/toxicidad , Replicación del ADN/efectos de los fármacos , Etopósido/toxicidad , Humanos , Hidroxiurea/toxicidad , Metotrexato/toxicidad , Mutagénesis , Radiación Ionizante , Proteína p53 Supresora de Tumor/genéticaRESUMEN
A somatic cell hybrid panel, consisting of 25 cell lines, has been developed to localize loci subregionally on chromosome 22. Over 300 markers in the form of STSs or hybridization probes have been assigned to one of 24 unique regions or "bins" using this panel. This ordered collection of markers will aid in the assembly of physical maps and contigs of chromosome 22 and assist in positional cloning of disease loci mapped to chromosome 22.
Asunto(s)
Cromosomas Humanos Par 22 , Enfermedades Genéticas Congénitas/genética , Animales , Secuencia de Bases , Línea Celular , Mapeo Cromosómico , Cricetinae , Cartilla de ADN , Sondas de ADN , Marcadores Genéticos , Técnicas Genéticas , Humanos , Células Híbridas , Datos de Secuencia Molecular , Reacción en Cadena de la PolimerasaRESUMEN
In order to study transcriptional regulation of hepatic genes during development, a method for transfer of fusion genes to primary cultures of fetal hepatocytes was required. The aim of this study was to assess currently available transfection methods and optimize the best method for use with cultured fetal hepatocytes. The Rous sarcoma virus 5' long terminal repeat controlling transcription of the beta-galactosidase reporter gene (pRSV lac Z II) was used to assess electroporation, lipofection, DEAE-dextran and calcium phosphate transfection in cultured primary fetal hepatocytes. The success of transfection was determined by histochemical detection and quantitation of beta-galactosidase activity. Results showed that calcium phosphate transfection was optimal for fetal hepatocytes with respect to beta-galactosidase activity and cell survival. For maximum transfection of cells, 10 micrograms/ml DNA, HEPES buffered saline transfection buffer at pH 7.05 and a 24 hr expression period for the reporter gene were employed. Glycerol shock did not increase transfection efficiency significantly. The method was simplified by adding calcium chloride solution to DNA diluted in transfection buffer and the resulting co-precipitate added directly to the medium covering the cells. Transfection 24 hr after initial culture and a precipitate incubation time of 20 hr were optimal. The suitability of this method was confirmed with a liver-specific promoter controlling beta-galactosidase and chloramphenicol acetyltransferase expression. In conclusion this study shows that a modified calcium phosphate transfection method is most effective for transferring DNA to primary cultured fetal hepatocytes. It is concluded that this method is appropriate for use with fetal hepatocytes and will facilitate studies of gene regulation during liver development.
Asunto(s)
Fosfatos de Calcio , Regulación del Desarrollo de la Expresión Génica/fisiología , Hígado/metabolismo , Animales , Células Cultivadas , Clonación Molecular , DEAE Dextrano , ADN/análisis , Electroporación , Desarrollo Embrionario y Fetal/fisiología , Liposomas , Hígado/citología , Fosfatidiletanolaminas , Regiones Promotoras Genéticas , Ratas , Ratas Wistar , TransfecciónRESUMEN
To date, only a small percentage of human genes have been cloned and mapped. To facilitate more rapid gene mapping and disease gene isolation, chromosome 5-specific cDNA libraries have been constructed from five sources. DNA sequencing and regional mapping of 205 unique cDNAs indicates that 25 are from known chromosome 5 genes and 138 are from new chromosome 5 genes (a frequency of 79.5%). Sequence complexity estimates indicate that each library contains -20% of the approximately 5000 genes that are believed to reside on chromosome 5. This study more than doubles the number of genes mapped to chromosome 5 and describes an important new tool for disease gene isolation.
Asunto(s)
Cromosomas Humanos Par 5 , Biblioteca de Genes , Secuencia de Bases , Mapeo Cromosómico , ADN Complementario , Genoma Humano , Células HeLa , Humanos , Datos de Secuencia Molecular , ARNRESUMEN
Deletion of the short arm of human chromosome 1 is the most common cytogenetic abnormality observed in neuroblastoma. To characterize the region of consistent deletion, we performed loss of heterozygosity (LOH) studies on 122 neuroblastoma tumor samples with 30 distal chromosome 1p polymorphisms. LOH was detected in 32 of the 122 tumors (26%). A single region of LOH, marked distally by D1Z2 and proximally by D1S228, was detected in all tumors demonstrating loss. Also, cells from a patient with a constitutional deletion of 1p36, and from a neuroblastoma cell line with a small 1p36 deletion, were analyzed by fluorescence in situ hybridization. Cells from both sources had interstitial deletions of 1p36.2-36.3 which overlapped the consensus region of LOH defined by the tumors. Interstitial deletion in the constitutional case was confirmed by allelic loss studies using the panel of polymorphic markers. Four proposed candidate genes--DAN, ID3 (heir-1), CDC2L1 (p58), and TNFR2--were shown to lie outside of the consensus region of allelic loss, as defined by the above deletions. These results more precisely define the location of a neuroblastoma suppressor gene within 1p36.2-36.3, eliminating 33 centimorgans of proximal 1p36 from consideration. Furthermore, a consensus region of loss, which excludes the four leading candidate genes, was found in all tumors with 1p36 LOH.
Asunto(s)
Deleción Cromosómica , Cromosomas Humanos Par 1 , Neuroblastoma/genética , Secuencia de Bases , Mapeo Cromosómico , Cartilla de ADN , Heterocigoto , Humanos , Hibridación Fluorescente in Situ , Datos de Secuencia MolecularRESUMEN
The pattern of gene expression in fetal hepatocytes transformed in culture with a hepatocarcinogen (FRL cells) is studied with respect to a range of markers which are either developmentally regulated and/or shown to be expressed at high levels in hepatoma cells. The relative abundance of the respective mRNAs is determined and immunocytochemistry is used to detect the respective proteins in cultured cells. When compared with its normal counterpart, FRL cells retain the expression of transferrin, alpha 1-acid glycoprotein, gamma-glutamyltranspeptidase, and tyrosine aminotransferase at near normal levels, while expression of the liver-specific isoenzymes of pyruvate kinase (L form) and aldolase (B form) is reduced. The cell lines are different in that they fail to express albumin, alpha-fetoprotein, thiostatin and alpha 2-macroglobulin, and they express high levels of M2-pyruvate kinase and aldolase A, markers often found in abundance in hepatoma cells. Therefore transformation has resulted in different effects on different genes. Furthermore, it is of interest to find that the cells coexpress both forms of the pyruvate kinase isoenzymes which does not occur in the normal developing hepatocyte. These results indicate that it is possible to use this model to study changes which accompany transformation of fetal rat hepatocytes. The resulting cell lines have a stable phenotype and retain the changes which result from transformation even after extended passaging. This facilitates comparisons between the precursor cell and the tumor cell, both of which can be maintained under controlled conditions which exist in culture.
Asunto(s)
Biomarcadores de Tumor , Carcinoma Hepatocelular/metabolismo , Transformación Celular Neoplásica , Neoplasias Hepáticas/metabolismo , Hígado/metabolismo , Animales , Northern Blotting , Carcinoma Hepatocelular/inmunología , Expresión Génica , Inmunohistoquímica , Técnicas In Vitro , Quininógenos/biosíntesis , Hígado/inmunología , Neoplasias Hepáticas/inmunología , Orosomucoide/biosíntesis , Piruvato Quinasa/biosíntesis , ARN Mensajero/análisis , Ratas , Transferrina/biosíntesis , Tirosina Transaminasa/biosíntesis , alfa-Macroglobulinas/biosíntesis , gamma-Glutamiltransferasa/biosíntesisRESUMEN
Studies were conducted to evaluate the effect of experimental protocol on the ability of benzidine (BZD), dimethylbenzanthracene (DMBA) and mitomycin C (MMC), administered by intraperitoneal injection, to induce micronuclei in polychromatic erythrocytes (PCE) of B6C3F1 mice. Three different treatment/sampling protocols were used, involving from one to three consecutive daily treatments and from three to one, respectively, consecutive daily samplings beginning 24 h after the last injection. DMBA and MMC elicited a significant micronucleus response in all three experimental protocols, while BZD induced a significant response only in the multiple injection protocols. Of the three protocols, the 3-day injection/single sample time protocol offers the greatest efficiency in minimizing the number of animals required in a study, in decreasing the time needed for scoring and in simplifying the statistical analysis. In addition, a comparison of the frequency of micronucleated PCE in peripheral blood and bone marrow following the treatment of mice with either BZD or DMBA suggests that, following a three injection protocol, either tissue can be used with equal efficacy.
Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Bencidinas/toxicidad , Aberraciones Cromosómicas , Pruebas de Micronúcleos , Mitomicinas/toxicidad , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , Análisis de Varianza , Animales , Bencidinas/administración & dosificación , Médula Ósea/efectos de los fármacos , Células de la Médula Ósea , Eritrocitos/efectos de los fármacos , Inyecciones Intraperitoneales , Masculino , Ratones , Mitomicina , Mitomicinas/administración & dosificación , Análisis de RegresiónRESUMEN
A study was undertaken comparing the outcomes of 30 women with infertility due to untreated severe (grade IV) pelvic endometriosis with a comparable series of 28 women whose infertility was caused solely by irreversible tubal disease. There were no significant differences in either the follicular phase or luteal phase hormonal profiles of estradiol and progesterone, but there was a significantly reduced pregnancy rate in those women with severe endometriosis. In part, this was due to the recovery of fewer oocytes from the endometriosis patients (P less than 0.001) despite the fact that the peak estradiol levels and ovarian accessibility were similar in the two groups. However, there were no significant differences in the proportion of oocytes that fertilized or the number that demonstrated normal embryo growth and high-grade embryo quality. There also appears to be an implantation inhibitory factor in patients with severe endometriosis as the pregnancy rate/embryo transferred and number of gestational sacs identified/embryo transferred were significantly reduced (P less than 0.05).